Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1609943 | 0.75 | — | — | |
| SCHEMBL3113206 | 0.74 | CYP1A2 (0.39) | ALDH1A1CYP1A2CYP2A6 | |
| SCHEMBL1611090 | 0.74 | — | — | |
| SCHEMBL1610998 | 0.73 | RAPGEF4 (0.32) | RAPGEF4 | |
| SCHEMBL1610960 | 0.73 | RAPGEF4 (0.32) | RAPGEF4 | |
| SCHEMBL18050282 | 0.71 | RAPGEF4 (0.43) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL7067381 | 0.71 | RAPGEF4 (0.43) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL18050283 | 0.71 | RAPGEF4 (0.43) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL1609706 | 0.70 | RAPGEF4 (0.30) | RAPGEF4 | |
| SCHEMBL28494872 | 0.69 | TTR (0.37) | KDM4EALDH1A1LMNAMAPTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2011-04-14 | — | — | US | disclosed |
| EP-2248818-A1 | ORGANIC SEMICONDUCTOR MATERIAL | Sumitomo Chemical Company, Limited (JP) | 2010-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | OR10J3, TST, OR51E2 | RAPGEF4 4209/4885KDM4E 1272/4885ALDH1A1 137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.